Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | solute carrier family 6 (neurotransmitter transporter), member 2 | Starlite/ChEMBL | References |
Homo sapiens | solute carrier family 6 (neurotransmitter transporter), member 3 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Sodium:neurotransmitter symporter family protein | solute carrier family 6 (neurotransmitter transporter), member 2 | 617 aa | 638 aa | 32.5 % |
Brugia malayi | Sodium:neurotransmitter symporter family protein | solute carrier family 6 (neurotransmitter transporter), member 3 | 620 aa | 579 aa | 33.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | sphingoid long chain base kinase | 0.0619 | 1 | 1 |
Mycobacterium tuberculosis | Conserved protein | 0.0619 | 1 | 0.5 |
Entamoeba histolytica | hypothetical protein, conserved | 0.0619 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0619 | 1 | 1 |
Schistosoma mansoni | sphingosine kinase A B | 0.0619 | 1 | 1 |
Brugia malayi | Sodium:neurotransmitter symporter family protein | 0.0219 | 0 | 0.5 |
Onchocerca volvulus | 0.0219 | 0 | 0.5 | |
Echinococcus multilocularis | sphingosine kinase 1 | 0.0619 | 1 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0619 | 1 | 0.5 |
Treponema pallidum | sodium- and chloride- dependent transporter | 0.0219 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 1731 nM | Displacement of [3H]Win35428 from human recombinant DAT over-expressed in CHOK1 cells | ChEMBL. | 24012181 |
IC50 (binding) | = 2521 nM | Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells | ChEMBL. | 24012181 |
Inhibition (binding) | = 6.2 % | Inhibition of human SERT-mediated serotonin uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis | ChEMBL. | 24012181 |
Inhibition (binding) | = 24.2 % | Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis | ChEMBL. | 24012181 |
Inhibition (binding) | = 26 % | Displacement of [3H]imipramin from human recombinant SERT over-expressed in HEK293 cells at 10 uM | ChEMBL. | 24012181 |
Inhibition (binding) | = 55 % | Inhibition of human DAT-mediated dopamine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis | ChEMBL. | 24012181 |
Inhibition (binding) | = 87 % | Displacement of [3H]Win35428 from human recombinant DAT over-expressed in CHOK1 cells at 10 uM | ChEMBL. | 24012181 |
Inhibition (binding) | = 90 % | Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM | ChEMBL. | 24012181 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.